Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Garforth

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 19, 2012
Pre-steady state kinetic analysis of cyclobutyl derivatives of 2'-deoxyadenosine 5'-triphosphate as inhibitors of HIV-1 reverse transcriptaseJiae Kim, Ligong Wang, Yongfeng Li, et al.
The Journal of Biological Chemistry|July 31, 2014
Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activationWen-I Tsou, Khanh-Quynh N Nguyen, Daniel A Calarese, et al.
The Journal of Clinical Investigation|December 1, 2022
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in miceMasayuki Kuraoka, Clare Burn Aschner, Ian W Windsor, et al.
Science Immunology|August 21, 2020
HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex virusesClare Burn Aschner, Lip Nam Loh, Benjamin Galen, et al.
Plos One|June 5, 2020
Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complexSarah C Garrett-Thomson, Aldo Massimi, Elena V Fedorov, et al.
Infection and Immunity|June 13, 2018
Identification of Mycobacterial Ribosomal Proteins as Targets for CD4<sup>+</sup> T Cells That Enhance Protective Immunity in TuberculosisSteven C Kennedy, Alison J Johnson, Sushma Bharrhan, et al.
The Journal of Clinical Investigation|October 21, 2021
T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized miceMengyan Li, Scott J Garforth, Kaitlyn E O'Connor, et al.
The Journal of Biological Chemistry|July 31, 2014
Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacityKhanh-Quynh N Nguyen, Wen-I Tsou, Daniel A Calarese, et al.
The Journal of Experimental Medicine|October 28, 2021
HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160Weifeng Liu, Ting-Fang Chou, Sarah C Garrett-Thomson, et al.
Nature|June 17, 2020
Author Correction: A naturally occurring antiviral ribonucleotide encoded by the human genomeAnthony S Gizzi, Tyler L Grove, Jamie J Arnold, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|May 19, 2012
Pre-steady state kinetic analysis of cyclobutyl derivatives of 2'-deoxyadenosine 5'-triphosphate as inhibitors of HIV-1 reverse transcriptaseJiae Kim, Ligong Wang, Yongfeng Li, et al.
The Journal of Biological Chemistry|July 31, 2014
Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activationWen-I Tsou, Khanh-Quynh N Nguyen, Daniel A Calarese, et al.
The Journal of Clinical Investigation|December 1, 2022
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in miceMasayuki Kuraoka, Clare Burn Aschner, Ian W Windsor, et al.
Science Immunology|August 21, 2020
HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex virusesClare Burn Aschner, Lip Nam Loh, Benjamin Galen, et al.
Plos One|June 5, 2020
Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complexSarah C Garrett-Thomson, Aldo Massimi, Elena V Fedorov, et al.
Infection and Immunity|June 13, 2018
Identification of Mycobacterial Ribosomal Proteins as Targets for CD4<sup>+</sup> T Cells That Enhance Protective Immunity in TuberculosisSteven C Kennedy, Alison J Johnson, Sushma Bharrhan, et al.
The Journal of Clinical Investigation|October 21, 2021
T cell receptor-targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized miceMengyan Li, Scott J Garforth, Kaitlyn E O'Connor, et al.
The Journal of Biological Chemistry|July 31, 2014
Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacityKhanh-Quynh N Nguyen, Wen-I Tsou, Daniel A Calarese, et al.
The Journal of Experimental Medicine|October 28, 2021
HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160Weifeng Liu, Ting-Fang Chou, Sarah C Garrett-Thomson, et al.
Nature|June 17, 2020
Author Correction: A naturally occurring antiviral ribonucleotide encoded by the human genomeAnthony S Gizzi, Tyler L Grove, Jamie J Arnold, et al.
Pageof 5